Hemostasis Diagnostics Market:Competitive Dynamics & Global Outlook 2024 Date: 03-26-2017 10:11 AM CET Category: Health & Medicine Press release from: Transparency Market Research - Medical Devices
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has gained a prominent position in the field of medicine and health care. Rising global prevalence of hemophilia A and B, the most common inherited bleeding disorders, significant surge in a variety of surgeries and trauma patients, and increasing use of recombinant products are the factors likely to drive the hemostasis diagnostics market in the near future. The rapid rate of introduction of cost effective and biodegradable products in the global market is also aiding the growth of the market. Growth across cost-sensitive emerging markets is essentially due to easy availability of cost-effective products. However, saturation of the global hemostasis market and high cost structures of advanced hemostasis products are hampering the growth of the market. Browse Global Strategic Business Report: www.transparencymarketresearch.com/hemostasis-diagnostics... The hemostasis diagnostics market has been segmented based on product type, end-user, and region. Based on product type, the hemostasis diagnostics market has been segmented into analyzers, reagents, and consumables. Analyzers can be further segmented into fully automated analyzers and semi-automated analyzers. Accuracy of hematology analyzers has been enhanced by automation of systems and use of cell surface marker labels. Automated analyzers function by sampling the blood and classifying cell populations by quantification and description. This may be carried out using both electrical and optical techniques. Sophisticated hematology blood cell analyzers are enabling precise disease diagnosis at an early stage. Fully-automated systems compact in size, easy to use, providing networking solutions, and efficient data management have increased adoption of hematology analyzers. In terms of end-user, the hemostasis diagnostics market has been segmented into hospitals, clinical testing laboratories, research & academic institutes, and others.
Seite 1 / 3